The Beauty Health Company
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of The Beauty Health Company generated cash of $21,750,000, which is more than the previous year. Cash used in financing activities reached the amount of -$37,448,000 last year. Net change in cash is therefore -$45,172,000.
Cash Flow
| 2018 | -895K | -8.44M | 11.16M |
|---|---|---|---|
| 2019 | 1.72M | -12.48M | 14.57M |
| 2020 | -12.43M | -3.81M | 18.27M |
| 2021 | -28.36M | -37.73M | 959.03M |
| 2022 | -106.6M | -18.86M | -205.24M |
| 2023 | 21.75M | -31.50M | -37.44M |
SKIN Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 568.19M | 901.88M | 9.48M | 7.30M | 3.57M | 1.75M |
Operating activities | ||||||
Net income | -100.11M | 44.38M | -375.10M | -29.17M | -1.63M | -317K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 34.67M | 22.01M | 21.13M | 14.40M | 13.88M | 11.49M |
Stock-based compensation expense | 22.54M | 28.49M | 12.41M | 363K | 103K | 61K |
| Deferred income tax benefit | 22.54M | 28.49M | 12.41M | 363K | 103K | 61K |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 12.85M | -32.02M | -31.01M | 3.70M | -11.04M | -7.71M |
Inventories | 19.56M | -82.09M | -9.44M | -3.21M | -4.76M | -9.79M |
Accounts payable | 15.78M | 1.60M | 10.52M | 4.88M | 4.31M | 4.17M |
Cash generated by operating activities | 21.75M | -106.6M | -28.36M | -12.43M | 1.72M | -895K |
Investing activities | ||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -13.04M | -17.39M | -15.61M | -3.81M | -10.42M | -7.88M |
Acquisitions Net | 0 | -1.47M | -22.89M | 0 | -2.05M | 0 |
Cash generated by investing activities | -31.50M | -18.86M | -37.73M | -3.81M | -12.48M | -8.44M |
Financing activities | ||||||
Common Stock Issued | 0 | 0 | 938.37M | -323K | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | -98.71M |
Repurchases of common stock | -32.39M | -160M | 0 | -154K | 0 | 0 |
Repayments of term debt | 0 | 0 | -230.48M | -16.77M | 16.5M | -5.02M |
Cash used in financing activities | -37.44M | -205.24M | 959.03M | 18.27M | 14.57M | 11.16M |
Net Change In Cash | -45.17M | -333.68M | 892.4M | 2.17M | 3.73M | 1.82M |
Cash at end of period | 523.02M | 568.19M | 901.88M | 9.48M | 7.30M | 3.57M |
| Data source | Data source | Data source | Data source |